Current share price for CCO : $0.005 0.001 (12.50%)
The Calmer Co International Limited (CCO, formerly Fiji Kava Limited) is a medicinal kava company based in Australia and the first foreign company with approval from the Fijian Government to operate in the kava industry. The Company has a vertically integrated supply chain in a true farm-to-shelf operation and has established a nucleus farm near Levuka, on the island of Ovalau, Fiji. Calmer Co is focussed on expanding the distribution of kava throughout global markets to provide a natural alternative to anti-anxiety prescription medicines. The Company sells its range of Therapeutic Goods Administration and Food and Drug Administration compliant Calmer Co products online and through retailers in Australia, Fiji, New Zealand, the United States.The Calmer Co International Limited (CCO, formerly Fiji Kava Limited) is a medicinal kava company based in Australia and the first foreign company with approval from the Fijian Government to operate in the kava industry. The Company has a vertically integrated supply chain in a true farm-to-shelf operation and has established a nucleus farm near Levuka, on the island of Ovalau, Fiji. Calmer Co is focussed on expanding the distribution of kava throughout global markets to provide a natural alternative to anti-anxiety prescription medicines. The Company sells its range of Therapeutic Goods Administration and Food and Drug Administration compliant Calmer Co products online and through retailers in Australia, Fiji, New Zealand, the United States.
Offer Open Date | 22 Oct 2018 |
Offer Close Date | 6 Nov 2018 |
Listing Date | 20 Dec 2018 |
Issue Price | $0.20 |
Amount Raised | $5,200,000 |
Shares Issued (new) | 26,000,000 |
Underwriter | |
Consultants | |
Auditor | Hall Chadwick WA |
Current Price | $0.00 | -97.75% |
First Day Open | n/a | n/a |
First Day High | n/a | n/a |
First Day Low | n/a | n/a |
First Day Close | n/a | n/a |
All-time High | $0.01 | -96% |
All-time Low | -100% | |
12-month High | $0.01 | -96% |
12-month Low | -100% |
Security Code | Company | Offer Open | Offer Close | Listing | Issue Price | Current Price | Gain |
---|---|---|---|---|---|---|---|
AMS | Atomos Limited | 10 Dec 2018 | 18 Dec 2018 | 28 Dec 2018 | $0.41 | $0.07 | -84.15% |
OPH | Ophir High Conviction Fund | 19 Dec 2018 | $2.15 | $2.59 | 20.47% | ||
EX1 | Exopharm Limited | 14 Nov 2018 | 4 Dec 2018 | 18 Dec 2018 | $0.20 | $0.01 | -94.50% |
YRL | Yandal Resources Limited | 3 Dec 2018 | 14 Dec 2018 | $0.20 | $0.15 | -25% | |
EMV | Emvision Medical Devices Limited | 19 Oct 2018 | 14 Nov 2018 | 13 Dec 2018 | $0.25 | $2.15 | 760% |
NVQ | Tymlez Group Limited | 7 Nov 2018 | 23 Nov 2018 | 13 Dec 2018 | $0.22 | $0.00 | -98.18% |
HMD | HeraMED Limited | 23 Oct 2018 | 16 Nov 2018 | 12 Dec 2018 | $0.20 | $0.02 | -91.25% |
XARO | Activex Ardea Real Outcome Bond Fund (Managed Fund | 10 Dec 2018 | $23.87 | ||||
A40 | Alliance Minerals Assets Limited | 16 Nov 2018 | 14 Dec 2018 | 5 Dec 2018 | $0.35 | $0.08 | -76.57% |
CRS | Caprice Resources Limited | 3 Nov 2018 | 5 Dec 2018 | $0.20 | $0.02 | -91% | |
RVS | Revasum Inc | 19 Nov 2018 | 30 Nov 2018 | 4 Dec 2018 | $2.00 | $0.12 | -94.25% |
RDC | Redcape Hotel Group | 12 Nov 2018 | 22 Nov 2018 | 30 Nov 2018 | $1.13 | $1.13 | 0% |
NVU | Nanoveu Limited | 7 Sep 2018 | 19 Oct 2018 | 30 Nov 2018 | $0.20 | $0.02 | -91.50% |
NWM | Norwest Minerals Limited | 26 Sep 2018 | 15 Oct 2018 | 29 Nov 2018 | $0.20 | $0.05 | -76.50% |
QRI | Qualitas Real Estate Income Fund | 16 Oct 2018 | 13 Nov 2018 | 27 Nov 2018 | $1.60 | $1.64 | 2.19% |
COL | Coles Group Limited | 21 Nov 2018 | $16.42 | ||||
SBW | Shekel Brainweigh Ltd | 24 Sep 2018 | 12 Oct 2018 | 20 Nov 2018 | $0.35 | $0.06 | -82.29% |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.